Hospital Variation in Premature Clopidogrel Discontinuation After Drug-Eluting Stent Placement in the Veterans Affairs (VA) Healthcare System

被引:4
|
作者
Vigen, Rebecca [1 ]
Maddox, Thomas M. [2 ,3 ,4 ]
O'Donnell, Colin I. [2 ]
Grunwald, Gary K. [2 ,3 ]
Bhatt, Deepak L. [5 ,6 ]
Tsai, Thomas T. [2 ,3 ,4 ]
Rumsfeld, John S. [2 ,3 ,4 ]
Ho, P. Michael [2 ,3 ,4 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[2] VA Eastern Colorado Hlth Care Syst, 1055 Clermont St,Res A151, Denver, CO 80220 USA
[3] Univ Colorado Denver, Aurora, CO USA
[4] CCOR Consortium, Denver, CO USA
[5] Brigham & Womens Hosp, VA Boston Healthcare Syst, 75 Francis St, Boston, MA 02115 USA
[6] Harvard Med Sch, Boston, MA USA
来源
关键词
adherence; clopidogrel; drug-eluting stents; CARDIOVASCULAR-DATA-REGISTRY; ANTIPLATELET THERAPY; PREDICTORS; IMPLANTATION; PREVALENCE;
D O I
10.1161/JAHA.114.001376
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Premature clopidogrel discontinuation after drug-eluting stent placement is associated with adverse outcomes. Little is known about patient and hospital factors associated with premature discontinuation or whether less variation in premature discontinuation exists in integrated health care systems such as the Veterans Affairs (VA). Methods and Results-We evaluated the frequency of premature clopidogrel discontinuation, defined as a gap between clopidogrel refills of >= 90 days during the first 6 months of treatment, among 12 707 patients who received drug-eluting stents in VA hospitals between 2008 and 2010. We evaluated the association between premature discontinuation and all-cause mortality and/or acute myocardial infarction, variation in the proportion of premature discontinuation among hospitals, the patient and hospital characteristics associated with premature discontinuation, and the extent to which unexplained hospital characteristics contribute to premature discontinuation. Of the patients, 963 (7.6%) discontinued clopidogrel prematurely. Premature discontinuation was associated with acute myocardial infarction and all-cause mortality (hazard ratio 1.65, 95% CI 1.37-1.99, P<0.001). The proportion of patients with premature discontinuation varied across hospitals from 0% to 16.5% (P<0.001). We found a median of 24% greater odds of patients with identical covariates with premature discontinuation at one randomly selected hospital compared with another (median odds ratio 1.24, 95% CI 1.17-1.44). Patient factors associated with premature discontinuation included lack of cardiology follow-up within 30 days of discharge and smaller initial clopidogrel fill. Conclusion-One in 13 patients prematurely discontinued clopidogrel, and variation in discontinuation across hospitals was observed. Patient factors were associated with premature discontinuation that may represent targets for quality improvement.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Stent length and outcomes after drug-eluting stent placement: time to redefine long lesions
    Lee, Cheol Whan
    Park, Seung-Jung
    CORONARY ARTERY DISEASE, 2017, 28 (06) : 452 - 453
  • [42] Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation
    In Sook Kang
    Islam Shehata
    Dong-Ho Shin
    Jung-Sun Kim
    Byeong-Keuk Kim
    Young-Guk Ko
    Donghoon Choi
    Yangsoo Jang
    Myeong-Ki Hong
    Heart and Vessels, 2016, 31 : 1405 - 1411
  • [43] Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation
    Kang, In Sook
    Shehata, Islam
    Shin, Dong-Ho
    Kim, Jung-Sun
    Kim, Byeong-Keuk
    Ko, Young-Guk
    Choi, Donghoon
    Jang, Yangsoo
    Hong, Myeong-Ki
    HEART AND VESSELS, 2016, 31 (09) : 1405 - 1411
  • [44] Delays in Filling Clopidogrel Prescription After Hospital Discharge and Adverse Outcomes After Drug-Eluting Stent Implantation Implications for Transitions of Care
    Ho, P. Michael
    Tsai, Thomas T.
    Maddox, Thomas M.
    Powers, J. David
    Carroll, Nikki M.
    Jackevicius, Cynthia
    Go, Alan S.
    Margolis, Karen L.
    DeFor, Terese A.
    Rumsfeld, John S.
    Magid, David J.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2010, 3 (03): : 261 - 266
  • [45] Economic impact of drug-eluting stents in a multiple hospital healthcare system
    Morneault, JA
    Kereiakes, DJ
    Wright, CB
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (6A): : 4H - 4H
  • [46] very late stent thrombosis after drug-eluting stent implantation in a patient without aspirin and clopidogrel resistance
    Lim, Sang Yup
    Kim, Ki Seok
    Joo, Seung Jae
    Jeong, Myung Ho
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2008, 23 (03) : 556 - 559
  • [47] Adjunctive Cilostazol Versus Double-Dose Clopidogrel After Drug-Eluting Stent Implantation
    Park, Kyung Woo
    Kang, Si-Hyuck
    Park, Jin Joo
    Yang, Han-Mo
    Kang, Hyun-Jae
    Koo, Bon-Kwon
    Park, Byoung-Eun
    Cha, Kwang Soo
    Rhew, Jay Young
    Jeon, Hui-Kyoung
    Shin, Eun Seok
    Oh, Ju Hyeon
    Jeong, Myung-Ho
    Kim, Sanghyun
    Hwang, Kyung-Kuk
    Yoon, Jung-Han
    Lee, Sung Yun
    Park, Tae-Ho
    Moon, Keon Woong
    Kwon, Hyuck-Moon
    Chae, In-Ho
    Kim, Hyo-Soo
    JACC-CARDIOVASCULAR INTERVENTIONS, 2013, 6 (09) : 932 - 942
  • [48] Single antiplatelet therapy with clopidogrel is safe after drug-eluting stent implantation in patients on anticoagulants
    Pasceri, Vincenzo
    Patti, Giuseppe
    Pelliccia, Francesco
    Pristipino, Christian
    Roncella, Adriana
    Irini, Diego
    Speciale, Giulio
    Di Sciascio, Germano
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : B1 - B1
  • [49] Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent
    Wang, Zhi Jian
    Zhou, Yu Jie
    Liu, Yu Yang
    Yu, Miao
    Shi, Dong Mei
    Zhao, Ying Xin
    Guo, Yong He
    Cheng, Wan Jun
    Jia, De An
    Cao, Zheng
    Nie, Bin
    Ge, Hai Long
    Yang, Shi Wei
    Yan, Zhen Man
    THROMBOSIS RESEARCH, 2009, 124 (01) : 46 - 51
  • [50] Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation
    Eisenstein, Eric L.
    Anstrom, Kevin J.
    Kong, David F.
    Shaw, Linda K.
    Tuttle, Robert H.
    Mark, Daniel B.
    Kramer, Judith M.
    Harrington, Robert A.
    Matchar, David B.
    Kandzari, David E.
    Peterson, Eric D.
    Schulman, Kevin A.
    Califf, Robert M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (02): : 159 - 168